Bacterial vaccines for the treatment of multiple sclerosis and other autoimmune disorders.
Rook
G A
GA
Dept of Medical Microbiology, Windeyer Institute of Medical Sciences, Royal Free and University College Medical School, London, UK. g.rook@ucl.ac.uk
Ristori
G
G
Salvetti
M
M
Giovannoni
G
G
Thompson
E J
EJ
Stanford
J L
JL
D000818:Animals; D001327:Autoimmune Diseases / Q000276:immunology / Q000628:therapy*; D001500:BCG Vaccine / Q000627:therapeutic use; D001428:Bacterial Vaccines / Q000627:therapeutic use*; D004195:Disease Models, Animal; D006360:Heat-Shock Proteins / Q000276:immunology / Q000378:metabolism; D006801:Humans; D007111:Immunity, Cellular; D009103:Multiple Sclerosis / Q000628:therapy; D050378:T-Lymphocytes, Regulatory / Q000276:immunology / Q000378:metabolism; D018417:Th1 Cells / Q000276:immunology; D018418:Th2 Cells / Q000276:immunology; D015854:Up-Regulation
D001500:BCG Vaccine; D001428:Bacterial Vaccines; D006360:Heat-Shock Proteins